Home
>
National Drug Code (NDC)
>
Octreotide Acetate
Octreotide Acetate - 0703-3301-04 - (Octreotide Acetate)
Drug Information of Octreotide Acetate
| Product NDC: | 0703-3301 |
| Proprietary Name: | Octreotide Acetate |
| Non Proprietary Name: | Octreotide Acetate |
| Active Ingredient(s): | 50 ug/mL & nbsp; Octreotide Acetate |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Octreotide Acetate
| Product NDC: | 0703-3301 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075957 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20051114 |
Package Information of Octreotide Acetate
| Package NDC: | 0703-3301-04 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-3301-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-3301-01) |
NDC Information of Octreotide Acetate
| NDC Code | 0703-3301-04 |
| Proprietary Name | Octreotide Acetate |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-3301-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-3301-01) |
| Product NDC | 0703-3301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Octreotide Acetate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20051114 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | OCTREOTIDE ACETATE |
| Strength Number | 50 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
